DUBLIN, June 17, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Generic Drugs Market 2016-2020" report to their offering.
The global generic drugs market to grow at a CAGR of 10.53% during the period 2016-2020.
Global Generic Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
One trend which is influencing market growth is the outsourcing of drug development. Vendors are increasingly using outsourcing as a business strategy as they have been experiencing a decline in venture capital investment. Some vendors outsource parts of their R&D process, such as product characterization testing, and toxicology testing, to contract research organizations. Similarly, some of them outsource parts or even the entirety of their manufacturing processes to other organizations. In this way, outsourcing is becoming a trend in the global generic drugs market.
According to the report, a key growth driver is the patent expiry of top-selling drugs. With many pharmaceutical drugs set to lose their patents during the forecast period, the competition in the generic market is expected to increase. Patent expiry of a branded drug results in the introduction of inexpensive generic drugs in the market. Branded drugs with sales of up to $135 billion expired by the end of 2015, offering pharmaceutical companies opportunities to capitalize on this market. Moreover, the patent expiry of drugs worth $150 billion by 2020 will fuel the growth of the global generic drugs market.
Further, the report states that one challenge that can have restrict market growth is the threat of counterfeit drugs.
To calculate the market size, it considers revenue generated from the sales of
- Simple generics
- Super generics
- Teva Pharmaceuticals
- Sun Pharmaceuticals
- STADA Arzneimittel
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Market research methodology
Part 04: Introduction
Part 05: Overview of generics
Part 06: Key leading countries
Part 07: Global pharmaceutical market
Part 08: Market landscape
Part 09: Market segmentation by category
Part 10: Market segmentation by therapeutic application
Part 11: Geographical segmentation
Part 12: Market drivers
Part 13: Impact of drivers
Part 14: Market challenges
Part 15: Impact of drivers and challenges
Part 16: Market trends
Part 17: Vendor landscape
Part 18: Appendix
For more information visit http://www.researchandmarkets.com/research/2b2whz/global_generic
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/research-and-markets---global-generic-drugs-market-2016---forecasts-to-2020-with-teva-sandoz-allergan-mylan-sun-pharma--stada-arzneimittel-dominating-300286470.html
SOURCE Research and Markets